 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | National Center for Tuberculosis Control and Prevention of China CDC |
| Street 1: | No. 155 Changbai Road /Changping District/Beijing/P.R.China |
| Street 2: | |
| City: | Beijing |
| Province: | Beijing |
| Post Code: | 102206 |
| Country: | China |
| Phone: | 86158900516 |
| Organization Email: | chenmt@chinatb.org |
| Web Site: | http://www.chinatb.org |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Countries |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Governmental Organization |
| Organization Type - Secondary: | None |
| Organization Description: | |
| National Center for Tuberculosis Control and Prevention is a speacial institute for tuberculosis control in China. It is responsible for the implementation of national TB control program(NTP) in China. Specifically, it is responsible for program/project planning, development of technical guidelines, training, surveillance, research, program monitoring and evaluation,laboratory reference and international collaboration. It's vision is to be the domestically and internationally recognized authority in TB and other related fields. From 2002, we have been carrying out several projects including WB/DFID China TB control project, Japan-assisted China TB control project, DFB China TB control project, CIDA-WHO China TB control project ,GFATM projects and Gates Foundation TB project. We are integrating all individual projects into NTP as a whole with most reasonable and effective allocation of various resources and proper management. In addition,We have begun our MDR-TB control and prevention program by Globe Fund'surpport and do research on MDR-TB diagnosis, treatment and management by Gates Foundation surport. But we still need more funding to fight the MDR-TB. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Delivery of health services and care Funding, including innovative and optimized approach to funding TB Care Provision of drugs, diagnostics and commodities Research and Development Technical Assistance |
Other Organization Information | |
| Total number of staff in your organization: | 51 - 99 |
| Number of full-time staff who are directly involved with TB: | 51 - 99 |
| Number of part-time staff who are directly involved with TB: | 0 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Attendance at a TB related event |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Information on developments within the TB world |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| NCTB is resposible for Chinese TB control plan | |
Geographical Reach | |
| Which country is your headquarters located in: | China |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
China |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Change the mode to TB srvice, let hospoital play an important role in TB control and prevntion. Drug-Resistant TB: MDR-TB diagnosis,treatment and management TB-HIV: early TB diagnosis to HIV and AIDS patient, early HIV detection to TB patient Laboratory Strengthening: laboratory reference, resaerch etc. New Diagnostics: rearch some new diagnosis regent. New TB Drugs: Begin to use some new TB drugs to treatment MDR-TB patient. New TB Vaccines: Try the second clinical test to a new TB Vaccine. Fundamental Research: have do some research in Diagnosis, vaccine and TB drugs. Research: have been done a lot of operational research about TB control and prevention. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | |
| Last updated: | February 20, 2013 |